Antiangiogenic Cancer Therapy

Discover the groundbreaking insights in Antiangiogenic Cancer Therapy, expertly edited by Taylor & Francis Inc. Published in 2007, this comprehensive hardback spans 876 pages and delves into the critical process of angiogenesis and its significant role in tumor growth and metastasis. This invaluable resource compiles the expertise of leading authorities in the field, exploring the latest angiogenesis inhibitors currently under clinical investigation, alongside early agents utilized in preclinical studies. With a focus on the unique aspects of targeting and inhibiting angiogenesis, this book is essential for researchers, clinicians, and anyone interested in the forefront of cancer therapy. Enhance your understanding of antiangiogenic strategies and their potential to revolutionize cancer treatment.